Results 111 to 120 of about 10,843 (242)

Effects of combined deferiprone and desferrioxamine iron chelating therapy in β‐thalassemia major end‐stage heart failure [PDF]

open access: bronze, 2006
Maurizio Porcu   +8 more
openalex   +1 more source

Deferiprone protects the isolated atria from cardiotoxicity induced by doxorubicin [PDF]

open access: bronze, 2006
Lingjie Xu   +6 more
openalex   +1 more source

Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment [PDF]

open access: gold, 2008
Sérgio Gonçalves   +3 more
openalex   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Studies of bone mineral density in children affected by dietary intolerances [PDF]

open access: yes, 2014
The Pediatric Department of the University of Ferrara has developed a special expertise in the field of hemoglobinopathies and has also an interest in gastrointestinal diseases.
Baldan, Alessandro   +3 more
core   +1 more source

Deferiprone Glucuronidation by Human Tissues and Recombinant UDP Glucuronosyltransferase 1A6: An in Vitro Investigation of Genetic and Splice Variants [PDF]

open access: green, 2008
Marie‐Odile Benoit‐Biancamano   +4 more
openalex   +1 more source

Correction to: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology [PDF]

open access: bronze, 2021
Shalini S. Rao   +6 more
openalex   +1 more source

A synopsis of current care of thalassaemia major patients in Hong Kong [PDF]

open access: yes, 2011
OBJECTIVE: To provide a synopsis of current thalassaemia major patient care in Hong Kong. DESIGN: Retrospective study. SETTING: All haematology units of the Hospital Authority in Hong Kong.
Au, WY   +18 more
core  

Home - About - Disclaimer - Privacy